paper-with-me

Papers

ERK/p38 MAPK inhibition reduces radio-resistance to pulsed proton beam in breast cancer stem cells cells

2015-07-15

Recent studies have identified highly tumorigenic cells with stem cell-like characteristics in human cancers, termed cancer stem cells (CSCs). CSCs are resistant to conventional radiotherapy and chemotherapy owing to their high DNA repair ability and oncogene overexpression. However, the mechanisms regulating CSC radio-resistance, particularly proton beam resistance, remain unclear. We isolated CSCs from the breast cancer cell lines MCF-7 and MDA-MB-231, which expressed the characteristic breast CSC membrane protein markers CD44+/CD24-/low, and irradiated the CSCs with pulsed proton beams. We confirmed that CSCs are resistant to pulsed proton beams and showed that treatment with p38 and ERK inhibitors reduced CSC radioresistance. Based on these results, BCSC radio-resistance can be reduced during proton beam therapy by co-treatment with ERK1/2 or p38 inhibitors, representing a novel approach for breast cancer therapy.

📄 PDF Abstract BibTeX arXiv:1509.02377

Code (0)

등록된 구현이 없습니다.

Similar Papers 제목 키워드 기반

Contextual Invertible World Models: A Neuro-Symbolic Agentic Framework for Colorectal Cancer Drug Response

2026-03-01 · Christopher Baker, Tianyu Ren, Karen Rafferty, Hui Wang arxiv

Precision oncology is currently limited by the small-N, large-P paradox, where high-dimensional genomic data is abundant but pharmacological response samples are sparse. While deep learning achieves predictive accuracy, …

IRE1 alpha may be causing abnormal loss of p53 at post transcriptional level in chronic myeloid leukemia

2017-01-19

Current treatment strategy for chronic myeloid leukemia (CML) mainly includes inhibition of tyrosine kinase activity, which has dramatically improved the prognosis of the disease but without cure. In addition some patien…

Prognosis

A mutual information-based in vivo monitoring of adaptive response to targeted therapies in melanoma

2021-01-10 · Aurore Bugi-Marteyn, Fanny Noulet, Nicolas Liaudet, Rastine Merat

The mechanisms of adaptive resistance to genetic-based targeted therapies of solid malignancies have been the subject of intense research. These studies hold great promise for finding co-targetable hub/pathways which in …

Suppressing evolution through environmental switching

2021-02-11 · Bryce Morsky, Dervis Can Vural

Ecology and evolution under changing environments are important in many subfields of biology with implications for medicine. Here, we explore an example: the consequences of fluctuating environments on the emergence of a…

Mathematical model of brain tumour growth with drug resistance

2020-12-15 · José Trobia, Kun Tian, Antonio Marcos Batista, Celso Grebogi 외

Brain tumours are masses of abnormal cells that can grow in an uncontrolled way in the brain. There are different types of malignant brain tumours. Gliomas are malignant brain tumours that grow from glial cells and are i…